Results 221 to 230 of about 6,843,765 (355)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Assessing the Association Between Meeting New 24-h Movement Guidelines and Symptoms of Depression, Anxiety, and Stress Among Chinese Medical Students: A Multicenter Study. [PDF]

Depress Anxiety
Ye X, Qin Z, Liu H, Tao Y, Ye W, Zhong Y, Shu L, Jiang R, Huang C.   +8 more
europepmc   +1 more source

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

Collagen processing is essential for germ cell identity

Biology Open
Sydney Roman, Nathalie Oulhen, Gerardo Reyes, Brenno Masina, Gary Wessel   +4 more
doaj   +1 more source

Using Technology to Transform Education: Aaron Doering Addresses Annual Meeting [PDF]

, 2016
Steve Hardin
openalex   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

User Involvement in Transition Care in Virtual 4-Party Meetings: A Qualitative Study. [PDF]

Health Expect
Høgsgaard D, Jensen JF, Andersen HM.
europepmc   +1 more source

THE SANITARY AND UNSANITARY RELATIONS OF UNDERGROUND WATERS.Read in the Section of State Medicine, at the Forty-second Annual Meeting of the American Medical Association, held at Washington, D. C., May, 1891.

, 1891
S. H. BRYCE
openalex   +2 more sources

Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen, Wenting Huang, Yitian Liu, Xuan Chen, Buyu Ke, Qian Shen, Hanyu Cai, Jing Sun, Yan Li, Yungang Cao, Beilei Hu, Keyang Chen   +11 more
wiley   +1 more source

A dedicated institutional clinical workflow and peer-review meeting for reirradiation. [PDF]

Tech Innov Patient Support Radiat Oncol
Dupuis P, Sandt M, Beldjoudi G, Moncharmont C, Serre AA, Claude L, Sunyach MP, Ayadi M.   +7 more
europepmc   +1 more source